Challenges and Future Perspectives for Vaccines Targeting the Tumor Microenvironment.

Immunotherapies integrating immune checkpoint inhibitors (ICI) represent the current standard of care for many solid cancers, yet they effectively treat only a minority of patients due to intrinsic or acquired resistance mechanisms [...].